Latest Integration News

Top Shelf International Holdings Limited has appointed voluntary administrators amid financial distress, with plans to continue trading while exploring sale or recapitalisation options. Shares remain suspended as the company seeks a path forward.

JAYRIDE Group has secured its first enterprise SaaS client with Thailand’s GB Limousine, marking a pivotal shift to recurring revenue and enterprise-grade transport software.

Simonds Group delivered stable FY25 revenue and modest EBITDA growth despite one-off acquisition expenses, positioning itself for growth through strategic product and channel expansion in FY26.

Simonds Group reported a stable $665.6 million revenue for FY25, with normalised net profit after tax surging 90% to $5.7 million, driven by the acquisition of Dennis Family Homes and improved margins.

Simonds Group Limited reported steady revenue of $665.6 million for FY2025, alongside a modest net profit of $1.015 million, as it completed the strategic acquisition of Dennis Family Homes. The company is focused on integrating the acquisition and driving growth amid a recovering housing market.

RocketDNA has secured a three-year contract to deploy its autonomous drone solution at the Gruyere Gold Mine, marking a significant step in integrating AI-powered surveying technology in mining operations.

CuFe Ltd announces a remarkable 400% increase in its Gecko copper-gold resource at Tennant Creek, boosting the total project resource to 24.3 million tonnes. This comprehensive update integrates decades of historical data and expands the deposit’s economic potential with byproduct metals.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

betr Entertainment Limited has launched a superior all-scrip takeover offer for PointsBet Holdings Limited, valuing PointsBet shares between $1.22 and $1.29 each and aiming to create Australia’s fourth largest online wagering operator. The deal promises substantial cost synergies and strategic growth opportunities.